Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Fedratinib hydrochloride hydrate (SAR 302503 hydrochloride hydrate) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 39.00 | |
10 mg | In stock | $ 55.00 | |
25 mg | In stock | $ 78.00 | |
50 mg | In stock | $ 102.00 | |
100 mg | In stock | $ 122.00 | |
200 mg | In stock | $ 197.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | Fedratinib hydrochloride hydrate (SAR 302503 hydrochloride hydrate) is a potent, selective, ATP-competitive and orally active JAK2 inhibitor. |
Targets&IC50 | JAK2:3 nM, FLT3:15 nM, RET:48 nM, JAK2 (V617F):3 nM |
Synonyms | TG-101348 hydrochloride hydrate, SAR 302503 hydrochloride hydrate |
Molecular Weight | 615.61 |
Formula | C27H40Cl2N6O4S |
CAS No. | 1374744-69-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (194.92 mM), Sonification is recommended.
H2O: 97 mg/mL (157.56 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Fedratinib hydrochloride hydrate 1374744-69-0 Angiogenesis Apoptosis Chromatin/Epigenetic JAK/STAT signaling Stem Cells JAK STAT5 JAK2V617F myeloproliferative TG-101348 hydrochloride Janus kinase phosphorylation anti-proliferation TG-101348 hydrochloride hydrate FLT3 inhibit TG-101348 hydrochloride Hydrate RET SAR 302503 hydrochloride hydrate orally Fedratinib hydrochloride Hydrate SAR 302503 hydrochloride anti-cancer SAR 302503 hydrochloride Hydrate JAK2 Inhibitor Fedratinib hydrochloride inhibitor